Use of Doublet or Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer Across Community-Based Urology Settings in the United States
This study demonstrated that darolutamide DT and TT are used ubiquitously across community urology practices in the United States for the treatment of mHSPC.
Authors
- Nicholas Lazarou
- Lauren Curry (ORCID: https://orcid.org/0000-0002-0243-5716)
- Benjamin Lowentritt (ORCID: https://orcid.org/0000-0002-2921-6249)
- Katie Grant
- Lorraine O’Donnell
- Bashir Kalayeh
- Israel Arango‐Hisijara
- Jay Jhaveri
- Sreevalsa Appukkuttan (ORCID: https://orcid.org/0000-0003-2537-1687)
- Audrey Himes
- Joelle Hamilton
- J. Eller
Institutions
- Bayer (United States) (US)
- Macula Vision Research Foundation (US)
- Chesapeake Urology Associates (US)
- Network Technologies (United States) (US)
Publication Details
- Journal
- Urology Practice
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1097/upj.0000000000000841
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00